ANIP vs HON · rev $503.5M vs P/E 36, rev $9.72B
ANI Pharmaceuticals Inc (ANIP) versus Honeywell International Inc (HON) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
ANIP currently screens at market cap $1.41B. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Not investment advice. Open the ANIP and HON stock pages for the full models.
Not investment advice.